Core Viewpoint - QScreen AI Inc. has officially changed its name from Predictmedix AI Inc. to better reflect its evolution into a broader screening and decision-intelligence platform, enhancing its market positioning and technology alignment [1][5][7]. Company Overview - QScreen AI Inc. is a provider of rapid health screening and remote patient care solutions globally, utilizing AI-powered Smarthealth AI stations to analyze physiological data and predict various health issues [8]. Name Change Details - The company's common shares will begin trading under the new symbol (CSE: QAI) on the Canadian Securities Exchange starting January 27, 2026, with no changes to share capital, business operations, or management [2][3][4]. Technological Evolution - The transition to QScreen AI Inc. signifies the company's advancement beyond traditional AI architectures, incorporating quantum-inspired and advanced computational techniques to enhance data processing and analysis [6][7]. Strategic Focus - The company aims to commercialize advanced, quantum-enhanced AI capabilities across healthcare, safety, and other high-value markets, with a focus on scaling and market penetration [7].

新浪科技讯 1月23日下午消息，今日举办的大湾区医疗健康创新大会上，广州卫健委宣布推出AI就医助 理"穗小伊"并正式入驻蚂蚁阿福App。市民下载阿福App，只需通过语音或文字与"穗小伊"互动，即可 获取健康咨询、智能挂号、候诊叫号、医保支付、报告查询与解读等全流程的智能服务。通过"穗小 伊"在线挂号和预约已覆盖广州医科大学附属医院、南方医院等在内的300多家医院，"云陪诊"服务也已 覆盖广州市50多家医院。 据悉，目前，全国已有包括重庆渝小健、广州穗小伊等多地城市级智能体入驻了蚂蚁阿福App，为用户 提供健康咨询、预约挂号、云陪诊、报告解读等多元服务。此外，黑龙江、新疆、郑州等10个地区将蚂 蚁阿福App作为"数字家医"的合作签约平台。 责任编辑：杨赐 新浪科技讯 1月23日下午消息，今日举办的大湾区医疗健康创新大会上，广州卫健委宣布推出AI就医助 理"穗小伊"并正式入驻蚂蚁阿福App。市民下载阿福App，只需通过语音或文字与"穗小伊"互动，即可 获取健康咨询、智能挂号、候诊叫号、医保支付、报告查询与解读等全流程的智能服务。通过"穗小 伊"在线挂号和预约已覆盖广州医科大学附属医院、南方医院等在内的300多家医 ...

Core Insights - Wang Teng, a former executive at Xiaomi, has successfully completed a seed round financing for his startup "Today’s Rest," raising tens of millions of yuan with investments from GL Ventures, Zhiyuan Robotics, Xilinmen, and Yunjiu Capital [1][2] - The company plans to launch a series of hardware and software products in the second half of the year and aims to expand internationally [1] - The product development will focus on brain science and artificial intelligence, aiming to reduce cognitive costs and enhance individual sleep and energy states [1] Company Overview - "Today’s Rest" is not merely defined as a smart bed or sleep monitoring device but introduces a long-term concept of "energy asset management," viewing human energy as a core asset that is often overlooked [1] - The company intends to evolve its product offerings based on technological capabilities and user needs, targeting tech-driven categories to create a closed-loop solution for energy perception, state adjustment, and long-term management [1] Leadership Background - Wang Teng was previously recognized as a promising talent at Xiaomi, holding positions such as General Manager of the REDMI brand and later as General Manager of Xiaomi's China marketing department [2] - His notable contributions at Xiaomi include the development of products like Mix2, Xiaomi 8, and Redmi Note 7 [2] - Following a dismissal from Xiaomi due to serious violations, Wang expressed regret and gratitude towards the company while announcing his entrepreneurial venture [2]

Core Insights - The article discusses the rapid growth of the calorie tracking app market, which reached $2.1 billion in 2023 and is projected to grow to $4.7 billion by 2032, driven by increasing health awareness and the prevalence of obesity and chronic diseases [3][4] - Cal AI targets ordinary users with a simplified interface, addressing the pain points of complex existing applications like MyFitnessPal, which often overwhelm users with features [5][6] - The app utilizes advanced AI models, achieving a food recognition accuracy of 90%, which is above the industry average, and focuses on user experience tailored to non-professional users [6][10] Market Trends - The demand for calorie tracking apps is evolving towards simplicity and ease of use, with a shift from fitness enthusiasts to the general public who prefer straightforward experiences [3][6] - Users are increasingly seeking specific features such as precise identification of food types and personalized guidance, prompting developers to create more targeted products [4][6] Product Features - Cal AI offers several key functionalities: food tracking through photo analysis, barcode scanning for nutritional information, weight monitoring with AI suggestions, and hydration and exercise tracking [11][12] - The app employs a free-to-use model with premium features, but users have expressed concerns about hidden subscription costs and the complexity of accessing full functionalities [14][15] Marketing Strategy - Initial marketing efforts focused on collaborations with fitness influencers on platforms like TikTok and Instagram, with a significant budget allocated for advertising [17] - The app's marketing expenditures have reportedly reached over $770,000 monthly, indicating a strong investment in user acquisition [17] Company Background - Cal AI was founded by a small team of four, leveraging the entrepreneurial experience of its founders, who have backgrounds in programming and growth marketing [19][20][21] - The company has achieved significant revenue growth, surpassing $1 million in revenue within four months of launch and stabilizing at over $2 million monthly [24][27] User Engagement - Cal AI boasts high user satisfaction ratings, with scores of 4.8 and 4.7 on App Store and Google Play, respectively, and a 30-day retention rate exceeding 30% [24] - The app's design and user experience are crafted to create emotional connections with users, enhancing engagement and retention [13][14]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：南财社 王腾自因泄密被小米辞退后，去向备受关注。 1月20日，王腾转发了投中网文章，宣布"今日宜休"完成总规模为数千万元的种子轮融资，投资方包括 高瓴创投（GL Ventures）、智元机器人、喜临门、云九资本等。据悉，公司将在今年下半年陆续发布 系列软硬件产品，并计划出海。 此前1月8日，小米前中国区市场部总经理王腾发文称，从小米离开后开始筹备创业，最近新公司已经成 立，公司取名为"今日宜休"，目标是通过研发睡眠健康相关的产品。王腾表示，目前已经组了一个初创 团队，核心成员主要来自小米、华为等头部科技大厂。 据悉，王腾新公司瞄准超3亿中国睡眠障碍人群，以'AI+脑科学'技术为核心，提供睡眠监测、干预与精 力管理的闭环解决方案，区别于传统助眠硬件。 天眼查App显示，北京今日宜休科技有限责任公司成立于2026年1月6日，到如今宣布拿到数千万融资， 仅用了14天，可见王腾的创业项目在创投圈受欢迎程度。不过值得注意的是，此轮融资资方中并未出现 小米系资本。 王腾透露，新公司薪资水平与福利待遇基本看齐大厂，并且会更侧重股权激励。同时，他 ...

Core Viewpoint - Alibaba Health has launched an AI product named "Hydrogen Ion," which has completed internal testing and is now available for download, targeting clinical and research doctors with a focus on low hallucination and high evidence-based capabilities [1] Group 1: Product Features - "Hydrogen Ion" emphasizes low hallucination and high evidence-based capabilities, providing authoritative sources for all answers and supporting one-click traceability to the original sources [1] - The product has shown high accuracy in evidence-based Q&A, evidence integration, and analysis, particularly in the context of clinical and research environments, aligning well with domestic doctors' habits [1] Group 2: Development and Application - The product represents the first commercialization of Alibaba Health's self-developed medical model, which is actively exploring applications in serious medical fields to enhance AI evidence-based capabilities in clinical decision-making and research [1] - The product logic of "Hydrogen Ion" is similar to the popular overseas product OpenEvidence but offers a more localized experience [1] Group 3: Strategic Positioning - Alibaba has previously established a presence in consumer health services through Tongyi Qianwen and Ant Financial, while serious medical applications are being handled by Alibaba Health, which has over ten years of experience in the healthcare sector [1] - This launch completes Alibaba's AI layout in the healthcare sector, achieving a comprehensive "C+D" end strategy [1]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Shanghai MediTrust Health Technology Group Co., Ltd.* 上海鎂信健康科技集團股份有限公司 (A joint stock company incorporated in the People's Republic of China with ...

Core Insights - Predictmedix AI Inc. has been selected for the Official Canada Trade Mission to Mexico, highlighting its status as a leader in AI-enabled health and safety technology [1][4][11] Group 1: Trade Mission Details - The trade mission is scheduled for February 15–20, 2026, focusing on key cities such as Mexico City, Guadalajara, and Monterrey [1] - This elite delegation includes only the most export-ready Canadian innovators, aligning with Canada's strategic priorities for global commercial alliances [2] - The mission is led by the Honourable Dominic LeBlanc, Minister responsible for Canada-U.S. Trade, and aims to provide access to Mexican business leaders and government decision-makers [3] Group 2: Strategic Importance - Participation in the trade mission validates Predictmedix's commercial maturity and international market appeal [4][11] - The mission supports Canada's national agenda for export diversification and innovation leadership, coinciding with growing economic momentum with Mexico [6] - Mexico's market, with over 130 million people, offers tariff-free access under CUSMA, making it an ideal location for technology deployment [5] Group 3: Technological Advancements - Predictmedix is emphasizing its integration of quantum-inspired algorithms into its AI framework, enhancing data processing speeds and diagnostic precision [7][9] - The company is onboarding industry veterans to lead its regional distribution network, leveraging their relationships in Mexico's healthcare and industrial sectors [10] Group 4: Commercial Objectives - The mission aims to expand Predictmedix's international sales pipeline and secure high-impact distribution partners [8] - The company is positioned to capitalize on high-growth sectors such as advanced manufacturing, ICT and AI, cleantech, and clean energy [6]

Industry Overview - The health and fitness industry has transformed into a significant global movement driven by a shift towards healthier living, with consumers seeking balanced nutrition and structured exercise routines [2] - Demand is increasing across gyms, supplements, and customized wellness programs, aided by technology that enhances personal health management through wearables and virtual coaching [2] - The global health and wellness market is projected to reach $11 trillion by 2034, growing at a 5.4% CAGR from 2025, driven by preventive care initiatives and workplace wellness programs [4] Key Players - Apple is enhancing its health and fitness offerings through the Apple Watch ecosystem and Fitness+ platform, integrating activity tracking with guided workouts [3] - Amazon is expanding its healthcare presence via One Medical, utilizing AI tools to improve access and convenience in health services [3] - United Natural Foods (UNFI) focuses on supplying natural and organic products that support healthier lifestyles, providing a range of groceries and wellness products [7][8] - The Vita Coco Company develops functional beverages, including coconut water and protein-infused drinks, aligning with health and fitness trends [11][12] - Doximity offers a digital platform for healthcare professionals, enhancing efficiency in healthcare delivery with tools for telehealth and administrative tasks [14][15] - Peloton Interactive combines high-end fitness equipment with digital content and community engagement, evolving towards a subscription-based model [17][19] Company Strategies - UNFI has adapted to consumer preferences for clean-label foods and has invested in distribution infrastructure to enhance efficiency and scale [8][9] - Vita Coco has expanded its product line to include fitness-focused beverages while maintaining brand leadership in the coconut water category [12][13] - Doximity has evolved into a comprehensive health technology solution, integrating telehealth and workflow tools to support healthcare professionals [15][16] - Peloton has shifted its strategy to emphasize subscription revenues, expanding its content library and diversifying distribution channels to reach a broader audience [19][20]

Core Insights - Tempus AI's stock experienced a significant increase, rising over 4% by the end of trading after a positive sales forecast was issued [1] Financial Performance - Tempus expects a revenue growth of 83% year over year, projecting $367 million in revenue for Q4, driven by a 121% increase in diagnostics sales to $266 million and a 25% rise in data and applications revenue to $100 million [3] - For the full year, the company forecasts sales growth of 83% to $1.27 billion, with organic sales projected to grow by 30% excluding the acquisition of Ambry Genetics in early 2025 [3] Business Development - The company reported a record total contract value exceeding $1.1 billion as of December 31, with over 70 clients, including major pharmaceutical companies like Pfizer, Novartis, and Eli Lilly, integrating Tempus' datasets into their drug development programs [5] - Tempus demonstrated strong customer retention with a net revenue retention rate of approximately 126% in 2025, indicating that existing customers are increasing their spending on Tempus' data offerings [6] Strategic Positioning - CEO Eric Lefkofsky stated that the company enters 2026 in a strong position, with both main business segments accelerating in growth and leveraging the financial advantages of their platform [4]